Safety of two-year caloric restriction in non-obese healthy individuals - PubMed (original) (raw)
Randomized Controlled Trial
Safety of two-year caloric restriction in non-obese healthy individuals
Sergei V Romashkan et al. Oncotarget. 2016.
Abstract
Background: The extent to which sustained caloric restriction (CR) in healthy non-obese adults is safe has not been previously investigated.
Objective: Assess the safety and tolerability of sustained two-year CR intervention in healthy, non-obese adults.
Design: A multi-center, randomized controlled trial. Participants were randomized using a 2:1 allocation in favor of 25% CR vs. Ad-Libitum intake (AL). Adverse and serious adverse events (AE, SAE), safety laboratory tests, and other safety parameters were closely monitored.
Results: Three participants were withdrawn from the CR intervention because of the safety concerns. No deaths and one SAE was reported by participants in the CR group. Although the difference in AE between AL and CR groups was not significant, within the CR group, the incidence of nervous system (p = 0.02), musculoskeletal (p = 0.02) and reproductive system (p = 0.002) disorders was significantly higher in the normal-weight than in the overweight participants. At months 12 and 24, bone mineral densities at the lumbar spine, total hip, and femoral neck of participants in the CR group were significantly lower than in those in the AL group.
Conclusions: Two-years of CR at levels achieved in CALERIE was safe and well tolerated. Close monitoring for excessive bone loss and anemia is important.
Keywords: Gerotarget; calorie restriction; dietary energy restriction; humans; safety.
Conflict of interest statement
CONFLICTS OF INTEREST
None reported.
Figures
Figure 1. Individual adverse events in CR participants in years 1 and 2 of CALERIE
Includes only AEs that occurred more often in the CR arm and were reported by at least 5% of CR participants.
Similar articles
- Effect of Two-Year Caloric Restriction on Bone Metabolism and Bone Mineral Density in Non-Obese Younger Adults: A Randomized Clinical Trial.
Villareal DT, Fontana L, Das SK, Redman L, Smith SR, Saltzman E, Bales C, Rochon J, Pieper C, Huang M, Lewis M, Schwartz AV; CALERIE Study Group. Villareal DT, et al. J Bone Miner Res. 2016 Jan;31(1):40-51. doi: 10.1002/jbmr.2701. Epub 2015 Sep 24. J Bone Miner Res. 2016. PMID: 26332798 Free PMC article. Clinical Trial. - Bone mineral density response to caloric restriction-induced weight loss or exercise-induced weight loss: a randomized controlled trial.
Villareal DT, Fontana L, Weiss EP, Racette SB, Steger-May K, Schechtman KB, Klein S, Holloszy JO. Villareal DT, et al. Arch Intern Med. 2006 Dec 11-25;166(22):2502-10. doi: 10.1001/archinte.166.22.2502. Arch Intern Med. 2006. PMID: 17159017 Clinical Trial. - Effect of 2-year caloric restriction on organ and tissue size in nonobese 21- to 50-year-old adults in a randomized clinical trial: the CALERIE study.
Shen W, Chen J, Zhou J, Martin CK, Ravussin E, Redman LM. Shen W, et al. Am J Clin Nutr. 2021 Oct 4;114(4):1295-1303. doi: 10.1093/ajcn/nqab205. Am J Clin Nutr. 2021. PMID: 34159359 Free PMC article. Clinical Trial. - The CALERIE Study: design and methods of an innovative 25% caloric restriction intervention.
Rickman AD, Williamson DA, Martin CK, Gilhooly CH, Stein RI, Bales CW, Roberts S, Das SK. Rickman AD, et al. Contemp Clin Trials. 2011 Nov;32(6):874-81. doi: 10.1016/j.cct.2011.07.002. Epub 2011 Jul 8. Contemp Clin Trials. 2011. PMID: 21767664 Free PMC article. Review. - Intermittent versus daily calorie restriction: which diet regimen is more effective for weight loss?
Varady KA. Varady KA. Obes Rev. 2011 Jul;12(7):e593-601. doi: 10.1111/j.1467-789X.2011.00873.x. Epub 2011 Mar 17. Obes Rev. 2011. PMID: 21410865 Review.
Cited by
- Calorie restriction in humans: An update.
Most J, Tosti V, Redman LM, Fontana L. Most J, et al. Ageing Res Rev. 2017 Oct;39:36-45. doi: 10.1016/j.arr.2016.08.005. Epub 2016 Aug 17. Ageing Res Rev. 2017. PMID: 27544442 Free PMC article. Review. - Role of Nicotinamide Adenine Dinucleotide and Related Precursors as Therapeutic Targets for Age-Related Degenerative Diseases: Rationale, Biochemistry, Pharmacokinetics, and Outcomes.
Braidy N, Berg J, Clement J, Khorshidi F, Poljak A, Jayasena T, Grant R, Sachdev P. Braidy N, et al. Antioxid Redox Signal. 2019 Jan 10;30(2):251-294. doi: 10.1089/ars.2017.7269. Epub 2018 May 11. Antioxid Redox Signal. 2019. PMID: 29634344 Free PMC article. Review. - 2 years of calorie restriction and cardiometabolic risk (CALERIE): exploratory outcomes of a multicentre, phase 2, randomised controlled trial.
Kraus WE, Bhapkar M, Huffman KM, Pieper CF, Krupa Das S, Redman LM, Villareal DT, Rochon J, Roberts SB, Ravussin E, Holloszy JO, Fontana L; CALERIE Investigators. Kraus WE, et al. Lancet Diabetes Endocrinol. 2019 Sep;7(9):673-683. doi: 10.1016/S2213-8587(19)30151-2. Epub 2019 Jul 11. Lancet Diabetes Endocrinol. 2019. PMID: 31303390 Free PMC article. Clinical Trial. - The effects of popular diets on bone health in the past decade: a narrative review.
Peng Y, Zhong Z, Huang C, Wang W. Peng Y, et al. Front Endocrinol (Lausanne). 2024 Mar 26;14:1287140. doi: 10.3389/fendo.2023.1287140. eCollection 2023. Front Endocrinol (Lausanne). 2024. PMID: 38665424 Free PMC article. Review. - Calorie Restriction and Aging in Humans.
Flanagan EW, Most J, Mey JT, Redman LM. Flanagan EW, et al. Annu Rev Nutr. 2020 Sep 23;40:105-133. doi: 10.1146/annurev-nutr-122319-034601. Epub 2020 Jun 19. Annu Rev Nutr. 2020. PMID: 32559388 Free PMC article.
References
- Weindruch R, Walford R. The retardation of Aging and Disease by Dietary Restriction. Thomas; New York. 1988
Publication types
MeSH terms
Grants and funding
- U24 AG047121/AG/NIA NIH HHS/United States
- U01 AG020487/AG/NIA NIH HHS/United States
- U01 AG020478/AG/NIA NIH HHS/United States
- U01 AG020480/AG/NIA NIH HHS/United States
- U01 AG022132/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical